Please use this identifier to cite or link to this item:
https://hdl.handle.net/11000/31049
Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients
Title: Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients |
Authors: Moreno-Pérez, Oscar LEON-RAMIREZ, JOSE-MANUEL ![](/image/ORCID.jpg) Fuertes Kenneally, Laura ![](/image/ORCID.jpg) Perdiguero, Miguel Garcia-Navarro, Mar Ruiz-Torregrosa, Paloma Boix, Vicente Gil, Joan Merino, Esperanza On behalf of COVID19-ALC Research Group |
Editor: Elsevier |
Department: Departamentos de la UMH::Medicina Clínica |
Issue Date: 2020 |
URI: https://hdl.handle.net/11000/31049 |
Abstract:
Objectives: Serum levels of potassium (K+) appear to be significantly lower in severe cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the clinical significance of this is unknown. The objective was to investigate whether hypokalemia acts as a biomarker of severity in coronavirus disease 2019 (COVID-19) pneumonia and is associated with major clinical outcomes.Methods: A retrospective cohort study of inpatients with COVID-19 pneumonia (March 3 to May 2, 2020) was performed. Patients were categorized according to nadir levels of K+ in the first 72 h of admission: hypokalemia (K+ ≤3.5 mmol/l) and normokalemia (K+ >3.5 mmol/l). The main outcomes were all-cause mortality and the need for invasive mechanical ventilation (IMV); these were analyzed by multiple logistic regression (odds ratio (OR), 95% confidence interval (CI)).Results: Three hundred and six patients were enrolled. Ninety-four patients (30.7%) had hypokalemia and these patients showed significantly higher comorbidity (Charlson comorbidity index ≥3, 30.0% vs 16.3%; p = 0.02) and CURB65 scores (median (interquartile range): 1.5 (0.0-3.0) vs 1.0 (0.0-2.0); p = 0.04), as well as higher levels of some inflammatory parameters at baseline. After adjustment for confounders, hypokalemia was independently associated with requiring IMV during the admission (OR 8.98, 95% CI 2.54-31.74). Mortality was 15.0% (n = 46) and was not influenced by low K+. Hypokalemia was associated with longer hospital and ICU stays.Conclusions: Hypokalemia is prevalent in patients with COVID-19 pneumonia. Hypokalemia is an independent predictor of IMV requirement and seems to be a sensitive biomarker of severe progression of COVID-19.
|
Keywords/Subjects: COVID19 pneumonia Cohort study Hypokalemia Mechanical ventilation Mortality |
Knowledge area: CDU: Ciencias aplicadas: Medicina: Patología. Medicina clínica. Oncología |
Type of document: application/pdf |
Access rights: info:eu-repo/semantics/openAccess |
DOI: https://doi.org/10.1016/j.ijid.2020.09.033 |
Appears in Collections: Artículos Medicina Clínica
|
???jsp.display-item.text9???